Skip Nav Destination
Issues
Onset of type 1 diabetes: a dynamical instability.
Topics:
diabetes mellitus, type 1
Diabetes September 1999, Vol.48, 1677-1685. doi:https://doi.org/10.2337/diabetes.48.9.1677
Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion.
Topics:
glucose
,
granules
,
insulin secretion
Diabetes September 1999, Vol.48, 1686-1690. doi:https://doi.org/10.2337/diabetes.48.9.1686
Long-term regulation of lipolysis and hormone-sensitive lipase by insulin and glucose.
Topics:
glucose
,
insulin
,
lipolysis
,
sterol esterase
Diabetes September 1999, Vol.48, 1691-1697. doi:https://doi.org/10.2337/diabetes.48.9.1691
Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia.
Topics:
glucokinase
,
glucose
,
hyperglycemia
,
models, structural
Diabetes September 1999, Vol.48, 1698-1705. doi:https://doi.org/10.2337/diabetes.48.9.1698
Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.
Topics:
glucose uptake
,
insulin
,
leptin
,
rats
,
sympathetic nervous system
Diabetes September 1999, Vol.48, 1706-1712. doi:https://doi.org/10.2337/diabetes.48.9.1706
Neonatal porcine islet cells induce human CD4+, but not CD8+, lymphocyte proliferation and resist cell-mediated cytolytic injury in vitro.
Topics:
cd8-positive t-lymphocytes
,
endocrine pancreas
,
newborn
,
suidae
Diabetes September 1999, Vol.48, 1713-1719. doi:https://doi.org/10.2337/diabetes.48.9.1713
Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.
I Bergerot; G A Arreaza; M J Cameron; M D Burdick; R M Strieter; S W Chensue; S Chakrabarti; T L Delovitch
Topics:
bodily secretions
,
cytokine
,
diabetes mellitus, type 1
,
insulin
,
pancreas
Diabetes September 1999, Vol.48, 1720-1729. doi:https://doi.org/10.2337/diabetes.48.9.1720
Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro.
Topics:
adenoviruses
,
apoptosis
,
endocrine pancreas
,
gene transfer techniques
,
interleukin-1 receptor antagonists
Diabetes September 1999, Vol.48, 1730-1736. doi:https://doi.org/10.2337/diabetes.48.9.1730
Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation.
Topics:
insulin
,
pancreas transplantation
Diabetes September 1999, Vol.48, 1737-1740. doi:https://doi.org/10.2337/diabetes.48.9.1737
Corticotropin-releasing factor modulation of Ca2+ influx in rat pancreatic beta-cells.
Topics:
calcium ions
,
corticotropin-releasing hormone
,
pancreas
Diabetes September 1999, Vol.48, 1741-1746. doi:https://doi.org/10.2337/diabetes.48.9.1741
Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets.
Diabetes September 1999, Vol.48, 1747-1753. doi:https://doi.org/10.2337/diabetes.48.9.1747
A defect late in stimulus-secretion coupling impairs insulin secretion in Goto-Kakizaki diabetic rats.
Topics:
bodily secretions
,
insulin secretion
,
rats
Diabetes September 1999, Vol.48, 1754-1762. doi:https://doi.org/10.2337/diabetes.48.9.1754
Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms.
Topics:
glucose
,
hypothalamus
,
pancreas
,
pancreatic beta cell
,
sensor
Diabetes September 1999, Vol.48, 1763-1772. doi:https://doi.org/10.2337/diabetes.48.9.1763
Expression of alpha-1 proteinase inhibitor in human islet microvascular endothelial cells.
Topics:
alpha 1-antitrypsin
,
endothelial cells
Diabetes September 1999, Vol.48, 1773-1778. doi:https://doi.org/10.2337/diabetes.48.9.1773
Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes.
Topics:
glucose tolerance
,
pancreatic beta cell
,
insulin
Diabetes September 1999, Vol.48, 1779-1786. doi:https://doi.org/10.2337/diabetes.48.9.1779
Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion.
N Satoh; Y Ogawa; G Katsuura; Y Numata; T Tsuji; M Hayase; K Ebihara; H Masuzaki; K Hosoda; Y Yoshimasa; K Nakao
Topics:
bodily secretions
,
catecholamines
,
hypothalamus
,
leptin
Diabetes September 1999, Vol.48, 1787-1793. doi:https://doi.org/10.2337/diabetes.48.9.1787
T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
A Oku; K Ueta; K Arakawa; T Ishihara; M Nawano; Y Kuronuma; M Matsumoto; A Saito; K Tsujihara; M Anai; T Asano; Y Kanai; H Endou
Diabetes September 1999, Vol.48, 1794-1800. doi:https://doi.org/10.2337/diabetes.48.9.1794
Altered hypothalamic function in response to glucose ingestion in obese humans.
Topics:
glucose
,
hypothalamus
,
ingestion
,
obesity
Diabetes September 1999, Vol.48, 1801-1806. doi:https://doi.org/10.2337/diabetes.48.9.1801
Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes.
Topics:
gestational diabetes
,
glucose transport
,
insulin receptor
,
obesity
,
phosphorylation
Diabetes September 1999, Vol.48, 1807-1814. doi:https://doi.org/10.2337/diabetes.48.9.1807
Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans.
Topics:
glucose uptake
,
leg
,
nitric oxide synthase
,
vascular flow
Diabetes September 1999, Vol.48, 1815-1821. doi:https://doi.org/10.2337/diabetes.48.9.1815
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.
Y Ogawa; H Masuzaki; K Hosoda; M Aizawa-Abe; J Suga; M Suda; K Ebihara; H Iwai; N Matsuoka; N Satoh; H Odaka; H Kasuga; Y Fujisawa; G Inoue; H Nishimura; Y Yoshimasa; K Nakao
Topics:
animals, transgenic
,
glucose metabolism
,
insulin sensitivity
,
leptin
,
mice
Diabetes September 1999, Vol.48, 1822-1829. doi:https://doi.org/10.2337/diabetes.48.9.1822
Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
Topics:
adipose tissue
,
gene expression
,
insulin resistance
,
mice
,
obesity
Diabetes September 1999, Vol.48, 1830-1835. doi:https://doi.org/10.2337/diabetes.48.9.1830
Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
A T Santomauro; G Boden; M E Silva; D M Rocha; R F Santos; M J Ursich; P G Strassmann; B L Wajchenberg
Topics:
glucose tolerance
,
insulin resistance
,
nonesterified fatty acids
,
obesity
Diabetes September 1999, Vol.48, 1836-1841. doi:https://doi.org/10.2337/diabetes.48.9.1836
Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
Diabetes September 1999, Vol.48, 1842-1849. doi:https://doi.org/10.2337/diabetes.48.9.1842
Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.
Topics:
erythrocytes
,
glutathione
,
lipid peroxidation
Diabetes September 1999, Vol.48, 1850-1855. doi:https://doi.org/10.2337/diabetes.48.9.1850
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
A E Caballero; S Arora; R Saouaf; S C Lim; P Smakowski; J Y Park; G L King; F W LoGerfo; E S Horton; A Veves
Topics:
diabetes mellitus, type 2
Diabetes September 1999, Vol.48, 1856-1862. doi:https://doi.org/10.2337/diabetes.48.9.1856
A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor.
Diabetes September 1999, Vol.48, 1863-1867. doi:https://doi.org/10.2337/diabetes.48.9.1863
Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study.
Topics:
aric trial
,
diabetes mellitus, type 2
,
fatty acid-binding proteins
,
genes
,
hyperinsulinism
Diabetes September 1999, Vol.48, 1868-1872. doi:https://doi.org/10.2337/diabetes.48.9.1868
Isolation, characterization, and chromosomal localization of the human ENSA gene that encodes alpha-endosulfine, a regulator of beta-cell K(ATP) channels.
Topics:
chromosomes
,
genes
,
pancreatic beta cell
Diabetes September 1999, Vol.48, 1873-1876. doi:https://doi.org/10.2337/diabetes.48.9.1873
Human insulin receptor substrate-2: gene organization and promoter characterization.
Topics:
gene organization
,
insulin receptor
Diabetes September 1999, Vol.48, 1877-1880. doi:https://doi.org/10.2337/diabetes.48.9.1877
A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance.
A Pizzuti; L Frittitta; A Argiolas; R Baratta; I D Goldfine; M Bozzali; T Ercolino; G Scarlato; L Iacoviello; R Vigneri; V Tassi; V Trischitta
Topics:
genes
,
glycoproteins
,
insulin resistance
,
open reading frames
,
polymorphism
Diabetes September 1999, Vol.48, 1881-1884. doi:https://doi.org/10.2337/diabetes.48.9.1881
Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence.
J E Ayala; R S Streeper; J S Desgrosellier; S K Durham; A Suwanichkul; C A Svitek; J K Goldman; F G Barr; D R Powell; R M O'Brien
Topics:
binding (molecular function)
,
catalytic domain
,
genes
,
glucose-6-phosphatase
,
insulin
Diabetes September 1999, Vol.48, 1885-1889. doi:https://doi.org/10.2337/diabetes.48.9.1885
Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis.
W K Chung; A Luke; R S Cooper; C Rotini; A Vidal-Puig; M Rosenbaum; M Chua; G Solanes; M Zheng; L Zhao; C LeDuc; A Eisberg; F Chu; E Murphy; M Schreier; L Aronne; S Caprio; B Kahle; D Gordon; S M Leal; R Goldsmith; A L Andreu; C Bruno; S DiMauro; R L Leibel
Topics:
genetics
,
homeostasis
,
uncoupling protein 3
Diabetes September 1999, Vol.48, 1890-1895. doi:https://doi.org/10.2337/diabetes.48.9.1890